0001415889-24-008033.txt : 20240314 0001415889-24-008033.hdr.sgml : 20240314 20240314180017 ACCESSION NUMBER: 0001415889-24-008033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240312 FILED AS OF DATE: 20240314 DATE AS OF CHANGE: 20240314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eldridge George A CENTRAL INDEX KEY: 0001413006 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40544 FILM NUMBER: 24751609 MAIL ADDRESS: STREET 1: C/O TARGANTA THERAPEUTICS CORPORATION STREET 2: 222 THIRD STREET SUITE 2300 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc. CENTRAL INDEX KEY: 0001798749 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831377888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-443-2400 MAIL ADDRESS: STREET 1: 930 WINTER STREET STREET 2: SUITE M-500 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-03142024_060304.xml X0508 4 2024-03-12 0001798749 Aerovate Therapeutics, Inc. AVTE 0001413006 Eldridge George A C/O AEROVATE THERAPEUTICS, INC. 930 WINTER STREET, SUITE M-500 WALTHAM MA 02451 false true false false SEE REMARKS 1 Common Stock 2024-03-12 4 M 0 2051 2.14 A 4011 D Common Stock 2024-03-12 4 S 0 2051 25.0461 D 1960 D Common Stock 2024-03-13 4 M 0 2016 2.14 A 3976 D Common Stock 2024-03-13 4 S 0 2016 25.0223 D 1960 D Stock Option (Right to Buy) 2.14 2024-03-12 4 M 0 2051 0 D 2031-04-01 Common Stock 2051 53279 D Stock Option (Right to Buy) 2.14 2024-03-13 4 M 0 2016 0 D 2031-04-01 Common Stock 2016 51263 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.08, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. Officer Title: Chief Financial Officer and Treasurer /s/ George A. Eldridge 2024-03-14